During the past decade, Robin K. Dore, MD, Inc. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Robin K. Dore, MD, Inc." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Robin K. Dore, MD, Inc." #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Robin K. Dore, MD, Inc." are "Rheumatoid Arthritis" (3 trials), "Systemic Lupus Erythematosus" (2 trials), "Active Cutaneous Lupus Erythematosus" (1 trials), "Active Systemic Lupus Erythematosus" (1 trials) and "Ankylosing Spondylitis" (1 trials). Many other conditions were trialed in "Robin K. Dore, MD, Inc." in a lesser frequency.

Most popular intervention types in "Robin K. Dore, MD, Inc." are "Drug" (10 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (3 trials), "TNF Inhibitor" (2 trials), "Apremilast (CC-10004)" (1 trials) and "Apremilast (CC-10004) Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Robin K. Dore, MD, Inc." are 10 trials for "All" genders.

Currently, there are NaN active trials in "Robin K. Dore, MD, Inc.". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Robin K. Dore, MD, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Robin K. Dore, MD, Inc., 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".